"Data from the United Kingdom points to a much reduced risk of VITT in second doses of the AstraZeneca vaccine and we look forward to providing more guidance in advance of people needing to receive their second dose of the AstraZeneca vaccine when their time for the second dose comes". Canada has agreements to purchase 20 million doses of the vaccine.
The newspaper quotes Kristin Klein, the co-lead of the province's vaccine task force, as saying the province has made a decision to shift to mRNA vaccines for first doses.
Researchers at Oxford University in the United Kingdom launched a study in February created to investigate the potential benefits of combining different vaccines that require two shots.
That condition has been given the term Vaccine Induced Immune Thrombotic Thrombocytopenia or VIIT. The US is "ramping up all of our efforts across the board in partnership with India and other countries to increase production of covid vaccines", he said.
AstraZeneca's contract with the European Union, which was signed by the Commission on behalf of the member countries last August, foresaw an initial 300 million doses for distribution among member countries, with an option for a further 100 million.
The chair of the National Advisory Committee on Immunization has since said, however, that those who already received a dose of AstraZeneca shouldn't feel like they made a poor choice.
AstraZeneca's controversial COVID-19 vaccine will no longer be administered in Ontario, according to the province's Chief Medical Officer of Health - or rather, the rollout of first doses of AZ will be "paused at this time".
"People need to be reassured that it's a good thing to have, particularly at the period of time that we needed it", she said. That includes both the original SARS-CoV-2 virus that causes COVID-19 and the B.1.1.7 variant of it.
"But in the same token, it means a lot of these countries are at risk that they will not get a second round of this vaccination".
Alberta started doling out AstraZeneca in March - at first to those aged 50 to 64 before revising eligibility to 55 and older, then lowering it to 40 in April and finally to 30 last week.
Among the findings, more than eight in 10 Canadian respondents said they are either vaccinated already or plan to be when it's their turn.
India and South Africa had in October moved a proposal, pressing WTO members for a waiver of certain rules of the TRIPS (Trade-Related Aspects of Intellectual Property Rights) pact.
The federal vaccine procurement centre told CTV Montreal that many more AstraZeneca doses are on the way: 655,000 COVAX doses "within the next number of weeks", and one million in June.
De Keersmaecker confirmed that the Commission did not exercise the option to buy an additional 100 million doses on the basis of the current agreement it sealed with the company.